AGITG 2013* Fotios Loupakis
University of Pisa, , Italy
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
First line treatment of colorectal cancer: 0, 1, 2, 3, 4 or 5 drugs? (10429)
8:00 AM
Fotios Loupakis
Meet the Professor Breakfast - sponsored by Roche
Implications for trial design and biomarker substudies (10566)
2:30 PM
Fotios Loupakis
Plenary - Biobanking - sponsored by Merck Serono